STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Neuronetics, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026

$1.91+0.02 (+1.33%)

Close on Oct 19, 2026

Market cap: $139.68M
P/E (TTM): –
Dividend yield: –

Neuronetics, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31
Revenue	149	75	71	65	55	49	63	53	40	34
Cost of Revenue	77	21	20	15	12	12	15	12	9.63	6.62
Gross Profit	72	54	52	50	44	38	47	40	31	28
Research & Development	6.58	13	9.52	9.34	7.92	9.20	14	8.23	7.94	8.22
Selling, General & Admin	97	76	73	75	63	51	60	52	36	29
Selling & Marketing	47	46	47	50	38	33	43	38	28	22
General & Administrative	50	30	25	26	26	18	17	14	8.57	6.93
Operating Expenses	104	89	82	85	71	60	74	60	44	37
Operating Income	-31	-35	-31	-35	-28	-22	-27	-20	-14	-9.34
Interest Expense	8.42	7.29	5.42	4.25	4.02	4.52	3.69	3.69	2.81	1.84
Other Non-Operating Income	0.72	2.55	5.79	2.20	0.39	0.30	1.57	-0.58	0.36	-0.06
Asset Impairment Charges	0	0	0	0	0	0	0	0	0	0
Gain (Loss) on Sale of Assets	-0.07	-0.03	–	–	–	–	–	–	–	–
Pretax Income	–	–	–	–	–	–	-29	-24	-16	-11
Net Income incl. Noncontrolling Interests	-39	-44	-30	-37	-31	-27	-29	-24	-16	-11
Minority Interest in Earnings	-0.14	-0.02	–	–	–	–	–	–	–	–
Net Income	-39	-44	-30	-37	-31	-27	-29	-24	-16	-11
EPS (Basic)(per share)	-0.59	-1.38	-1.05	-1.38	-1.22	-1.46	-1.58	-2.69	-86.34	-76.95
EPS (Diluted)(per share)	-0.59	-1.38	-1.05	-1.38	-1.22	-1.46	-1.58	-2.69	-86.34	-76.95
Shares Outstanding (Basic, Weighted)(shares)	66	32	29	27	25	19	18	8.95	0.19	0.15
Shares Outstanding (Diluted, Weighted)(shares)	66	32	29	27	25	19	18	8.95	0.19	0.15
EBITDA	-28	-32	-29	-33	-27	-21	-26	-19	-13	-8.66

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 49.1%
Operating margin: -14.7%
Net margin: -19.6%
Return on equity, FY2025: -155.7%

Financial strength

Current ratio: 1.88
Debt to equity: 3.45
Debt to assets: 46.8%
Cash to current liabilities: 67.8%

Valuation

P/E ratio: –
Price to sales: 0.90
Price to book: 7.83
Dividend yield: –